Open AccessNo Effect of Statin Therapy on Silent Myocardial Ischemia in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease
Author(s) -
Edith D. Beishuizen,
J. Wouter Jukema,
Jouke T. Tamsma,
Marcel A. van de Ree,
J. C. M. van der Vijver,
Hein Putter,
Arie C. Maan,
A. Edo Meinders,
Menno V. Huisman
Publication year - 2005
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/diacare.28.7.1675
Subject(s) - medicine , cerivastatin , diabetes mellitus , placebo , type 2 diabetes , statin , coronary artery disease , simvastatin , cardiology , ambulatory , ischemia , cholesterol , endocrinology , pathology , alternative medicine , pravastatin
Coronary artery disease is the most important cause of mortality in patients with type 2 diabetes. We aimed to determine the prevalence of silent myocardial ischemia (SMI) and the effect of statin therapy on SMI in type 2 diabetic patients without manifest cardiovascular disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom